DAVENAL HOUSE SURGERY PARTNERSHIP — All Prescriptions & Medications — Page 2
Practice Code: M81069 | BROMSGROVE, B61 0DD
Showing results 51-100 of 587
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Hydroxocobalamin | 870 | 1,211 | £2.5K | +80.8% ▲ |
| Tramadol hydrochloride | 863 | 82.6K | £2.5K | +20.4% ▲ |
| 862 | 2,137 | £75.7K | +58.1% ▲ | |
| Senna | 830 | 44.9K | £1.0K | +37.9% ▲ |
| Quetiapine | 811 | 32.0K | £7.0K | +30.3% ▲ |
| Progesterone | 803 | 66.3K | £14.3K | +91.8% ▲ |
| Rosuvastatin calcium | 751 | 29.2K | £830 | -16.3% ▼ |
| Rivaroxaban | 739 | 29.7K | £21.0K | +20.8% ▲ |
| Venlafaxine | 735 | 33.1K | £6.6K | -13.0% ▼ |
| Latanoprost | 731 | 11.2K | £3.9K | +50.6% ▲ |
| Atenolol | 728 | 32.3K | £722 | +20.7% ▲ |
| Flucloxacillin sodium | 707 | 32.9K | £1.8K | +57.2% ▲ |
| Nitrofurantoin | 695 | 10.6K | £5.0K | +45.6% ▲ |
| Felodipine | 686 | 31.0K | £4.9K | +15.5% ▲ |
| Zopiclone | 686 | 14.5K | £602 | +23.9% ▲ |
| Sildenafil (Erectile Dysfunction) | 686 | 5,172 | £726 | +36.1% ▲ |
| Digoxin | 685 | 24.5K | £1.8K | +81.0% ▲ |
| Finasteride | 684 | 25.2K | £901 | +4.5% ▲ |
| Indapamide | 680 | 29.6K | £826 | -21.2% ▼ |
| Docusate sodium | 679 | 127.1K | £7.4K | +83.1% ▲ |
| Melatonin | 650 | 33.8K | £9.6K | +95.5% ▲ |
| Nefopam hydrochloride | 646 | 68.0K | £2.9K | +471.1% ▲ |
| Desogestrel | 637 | 67.0K | £2.0K | +60.7% ▲ |
| 637 | 11.1K | £6.9K | -4.1% ▼ | |
| Other emollient preparations | 633 | 344.5K | £4.3K | +5.4% ▲ |
| Lactulose | 629 | 370.4K | £3.4K | +91.1% ▲ |
| Lercanidipine hydrochloride | 623 | 24.2K | £2.3K | +0.9% vs avg |
| Mometasone furoate | 603 | 718 | £5.6K | +50.2% ▲ |
| Fexofenadine hydrochloride | 594 | 23.0K | £1.0K | -30.1% ▼ |
| Bendroflumethiazide | 577 | 26.3K | £430 | -25.4% ▼ |
| Risperidone | 575 | 27.8K | £9.4K | +127.3% ▲ |
| Levetiracetam | 566 | 76.8K | £4.2K | +23.6% ▲ |
| Carbocisteine | 559 | 83.0K | £2.5K | +4.7% ▲ |
| Sumatriptan succinate | 548 | 5,766 | £2.3K | +54.7% ▲ |
| Glucose blood testing reagents | 536 | 48.8K | £8.2K | -32.1% ▼ |
| Lisinopril | 532 | 30.6K | £691 | -51.5% ▼ |
| Fluticasone/umeclidinium/vilanterol | 532 | 709 | £29.8K | +126.9% ▲ |
| Solifenacin | 525 | 23.1K | £854 | +10.0% ▲ |
| Methotrexate | 525 | 11.4K | £6.8K | +61.3% ▲ |
| Esomeprazole | 522 | 23.5K | £1.8K | +29.0% ▲ |
| Betamethasone valerate | 522 | 40.5K | £2.6K | +35.6% ▲ |
| Methylphenidate hydrochloride | 520 | 20.9K | £16.2K | +101.3% ▲ |
| Spironolactone | 518 | 19.1K | £1.5K | -3.9% ▼ |
| 506 | 63.1K | £4.1K | +6.6% ▲ | |
| Olanzapine | 490 | 12.9K | £1.6K | +32.3% ▲ |
| Insulin glargine | 489 | 2,243 | £18.5K | +72.2% ▲ |
| Duloxetine hydrochloride | 487 | 20.9K | £1.6K | -23.4% ▼ |
| Montelukast | 486 | 18.3K | £882 | -29.0% ▼ |
| Alginic acid compound preparations | 475 | 248.8K | £3.2K | -18.9% ▼ |
| Lamotrigine | 475 | 32.7K | £2.7K | -19.6% ▼ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.